GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

CNMD · Sep 30, 2026

CONMED Corp. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0000816956-26-000111General Corporate
Debt relative to revenue25thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.debt_to_revenue

189.46% · OPTIONAL · VALID

Capex intensityRAWCurrent state valid · history insufficient
Evidence method

Level · gp.fundamentals.capex_revenue_ratio

0.80% · OPTIONAL · NOT_ENOUGH_HISTORY

Operating cash generationRAWCurrent state valid · history insufficient
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

14.73% · OPTIONAL · NOT_ENOUGH_HISTORY

Revenue growthRAWCurrent state valid · history insufficient
Evidence method

Yoy · gp.fundamentals.revenue

-0.70% · CORE · NOT_ENOUGH_HISTORY

Inventory pressure75thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.inventory_revenue_ratio

108.13% · OPTIONAL · VALID

Gross margin75thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.gross_margin

56.37% · CORE · VALID

Operating margin50thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.operating_margin

11.07% · CORE · VALID

R&D intensity100thOwn-history percentile · N=8
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

4.65% · OPTIONAL · VALID

SBC intensity38thOwn-history percentile · N=8
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

1.76% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History3 statesHistory building
Jun 30, 20240/8 normalizedLevel 3Sep 30, 20240/8 normalizedLevel 3Sep 30, 20266/9 normalizedLevel 3
Period transition

What moved in the state?

Balance Sheet Leverage Decreased
Previous
191.29%
Current
189.46%
Delta
-1.82%
Growth Decreased
Previous
0.33%
Current
-0.70%
Delta
-1.03%
Inventory Pressure Increased
Previous
104.86%
Current
108.13%
Delta
3.27%
Margin Decreased
Previous
57.49%
Current
56.37%
Delta
-1.12%
Profitability Increased
Previous
10.60%
Current
11.07%
Delta
0.47%
R And D Intensity Increased
Previous
4.51%
Current
4.65%
Delta
0.13%
Sbc Intensity Increased
Previous
1.52%
Current
1.76%
Delta
0.24%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Compared To · Electromedical & Electrotherapeutic Apparatus peers →Derived From · CNMD Company Quality Vector →Has State · CONMED Corp →Transitioned To · CNMD BALANCE_SHEET_LEVERAGE_DECREASED →Transitioned To · CNMD GROWTH_DECREASED →Transitioned To · CNMD INVENTORY_PRESSURE_INCREASED →Transitioned To · CNMD MARGIN_DECREASED →Transitioned To · CNMD PROFITABILITY_INCREASED →Transitioned To · CNMD R_AND_D_INTENSITY_INCREASED →Transitioned To · CNMD SBC_INTENSITY_INCREASED →

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.